Activity of mecillinam against USA urinary tract clinical isolates from 2017 to 2020 including isolates resistant to comparator antibiotics

Activity of mecillinam against USA urinary tract clinical isolates from 2017 to 2020 including isolates resistant to comparator antibiotics

Objectives: To support the clinical development of mecillinam and pivmecillinam in the United States for the treatment of complicated and uncomplicated urinary tract infections (UTIs), this study investigated the activity of mecillinam compared with other antibiotics against Enterobacterales isolate...

Full description

Bibliographic Details
Main Authors: Stephen Hawser, Ian Morrissey, Nimmi Kothari, Federica Monti, Anne Santerre Henriksen
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Methicillin
Enterobacterales
Esbl
Gram-negative
United States
Resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524001656

Internet

http://www.sciencedirect.com/science/article/pii/S2213716524001656

Similar Items